The authors of Yet another paper noted the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [eleven].Though situation stories can provide important insights into unique clinical situations, they usually absence generalizability and so